These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 29403003)
41. T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice. Schüler T; Qin Z; Ibe S; Noben-Trauth N; Blankenstein T J Exp Med; 1999 Mar; 189(5):803-10. PubMed ID: 10049944 [TBL] [Abstract][Full Text] [Related]
42. Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1. Cohen N; Shani O; Raz Y; Sharon Y; Hoffman D; Abramovitz L; Erez N Oncogene; 2017 Aug; 36(31):4457-4468. PubMed ID: 28368410 [TBL] [Abstract][Full Text] [Related]
43. Intratumoral injection of interferon-gamma gene-modified dendritic cells elicits potent antitumor effects: effective induction of tumor-specific CD8+ CTL response. Pan J; Zhang M; Wang J; Wang Q; Xia D; Sun W; Zhang L; Yu H; Cao X J Cancer Res Clin Oncol; 2005 Jul; 131(7):468-78. PubMed ID: 15711825 [TBL] [Abstract][Full Text] [Related]
44. A small molecule targeting CHI3L1 inhibits lung metastasis by blocking IL-13Rα2-mediated JNK-AP-1 signals. Lee YS; Yu JE; Kim KC; Lee DH; Son DJ; Lee HP; Jung JK; Kim ND; Ham YW; Yun J; Han SB; Hong JT Mol Oncol; 2022 Jan; 16(2):508-526. PubMed ID: 34758182 [TBL] [Abstract][Full Text] [Related]
45. An agonistic anti-Toll-like receptor 4 monoclonal antibody as an effective adjuvant for cancer immunotherapy. Tsukamoto H; Kubota K; Shichiku A; Maekawa M; Mano N; Yagita H; Ohta S; Tomioka Y Immunology; 2019 Oct; 158(2):136-149. PubMed ID: 31515801 [TBL] [Abstract][Full Text] [Related]
46. Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer. Yu JE; Yeo IJ; Han SB; Yun J; Kim B; Yong YJ; Lim YS; Kim TH; Son DJ; Hong JT Exp Mol Med; 2024 Feb; 56(1):1-18. PubMed ID: 38177294 [TBL] [Abstract][Full Text] [Related]
47. An essential role of Th1 responses and interferon gamma in infection-mediated suppression of neoplastic growth. Rankin EB; Yu D; Jiang J; Shen H; Pearce EJ; Goldschmidt MH; Levy DE; Golovkina TV; Hunter CA; Thomas-Tikhonenko A Cancer Biol Ther; 2003; 2(6):687-93. PubMed ID: 14688478 [TBL] [Abstract][Full Text] [Related]
48. Chitinase 3-like-1 regulates both visceral fat accumulation and asthma-like Th2 inflammation. Ahangari F; Sood A; Ma B; Takyar S; Schuyler M; Qualls C; Dela Cruz CS; Chupp GL; Lee CG; Elias JA Am J Respir Crit Care Med; 2015 Apr; 191(7):746-57. PubMed ID: 25629580 [TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of T helper 1 and 2 and T cytotoxic 1 and 2 cells in patients with non-small cell lung cancer. Ito N; Suzuki Y; Taniguchi Y; Ishiguro K; Nakamura H; Ohgi S Anticancer Res; 2005; 25(3B):2027-31. PubMed ID: 16158940 [TBL] [Abstract][Full Text] [Related]
50. Sustained antigen-specific antitumor recall response mediated by gene-modified CD4+ T helper-1 and CD8+ T cells. Moeller M; Kershaw MH; Cameron R; Westwood JA; Trapani JA; Smyth MJ; Darcy PK Cancer Res; 2007 Dec; 67(23):11428-37. PubMed ID: 18056471 [TBL] [Abstract][Full Text] [Related]
51. Chitinase 3-Like-1-Deficient Splenocytes Deteriorated the Pathogenesis of Acute Graft-Versus-Host Disease via Regulating Differentiation of Tfh Cells. Li Z; Lu H; Gu J; Liu J; Zhu Q; Lu Y; Wang X Inflammation; 2017 Oct; 40(5):1576-1588. PubMed ID: 28656528 [TBL] [Abstract][Full Text] [Related]
52. Control of established melanoma by CD27 stimulation is associated with enhanced effector function and persistence, and reduced PD-1 expression of tumor infiltrating CD8(+) T cells. Roberts DJ; Franklin NA; Kingeter LM; Yagita H; Tutt AL; Glennie MJ; Bullock TN J Immunother; 2010 Oct; 33(8):769-79. PubMed ID: 20842060 [TBL] [Abstract][Full Text] [Related]
53. Chitinase-3-like-1 deficiency attenuates ethanol-induced liver injury by inhibition of sterol regulatory element binding protein 1-dependent triglyceride synthesis. Lee DH; Han JH; Lee YS; Jung YS; Roh YS; Yun JS; Han SB; Hong JT Metabolism; 2019 Jun; 95():46-56. PubMed ID: 30935969 [TBL] [Abstract][Full Text] [Related]
54. Regulation by Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 of alpha-galactosylceramide-induced antimetastatic activity and Th1 and Th2 responses of NKT cells. Okajo J; Kaneko Y; Murata Y; Tomizawa T; Okuzawa C; Saito Y; Kaneko Y; Ishikawa-Sekigami T; Okazawa H; Ohnishi H; Matozaki T; Nojima Y J Immunol; 2007 May; 178(10):6164-72. PubMed ID: 17475843 [TBL] [Abstract][Full Text] [Related]
55. Anti-PD1 antibody enhances the anti-tumor efficacy of MUC1-MBP fusion protein vaccine via increasing Th1, Tc1 activity and decreasing the proportion of MDSC in the B16-MUC1 melanoma mouse model. Zhang Z; Zhou H; Liu Y; Ren J; Wang J; Sang Q; Lan Y; Wu Y; Yuan H; Ni W; Tai G Int Immunopharmacol; 2021 Dec; 101(Pt A):108173. PubMed ID: 34607233 [TBL] [Abstract][Full Text] [Related]
56. Role of Chitinase 3-Like-1 in Interleukin-18-Induced Pulmonary Type 1, Type 2, and Type 17 Inflammation; Alveolar Destruction; and Airway Fibrosis in the Murine Lung. Kang MJ; Yoon CM; Nam M; Kim DH; Choi JM; Lee CG; Elias JA Am J Respir Cell Mol Biol; 2015 Dec; 53(6):863-71. PubMed ID: 25955511 [TBL] [Abstract][Full Text] [Related]
57. Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes. Tsuji T; Yasukawa M; Matsuzaki J; Ohkuri T; Chamoto K; Wakita D; Azuma T; Niiya H; Miyoshi H; Kuzushima K; Oka Y; Sugiyama H; Ikeda H; Nishimura T Blood; 2005 Jul; 106(2):470-6. PubMed ID: 15790789 [TBL] [Abstract][Full Text] [Related]
58. Immunomodulation of Host Chitinase 3-Like 1 During a Mammary Pathogenic Breyne K; Steenbrugge J; Demeyere K; Lee CG; Elias JA; Petzl W; Smith DGE; Germon P; Meyer E Front Immunol; 2018; 9():1143. PubMed ID: 29892291 [TBL] [Abstract][Full Text] [Related]
59. Mesenchymal stem cells alleviate experimental immune-mediated liver injury via chitinase 3-like protein 1-mediated T cell suppression. Liu Q; Chen X; Liu C; Pan L; Kang X; Li Y; Du C; Dong S; Xiang AP; Xu Y; Zhang Q Cell Death Dis; 2021 Mar; 12(3):240. PubMed ID: 33664231 [TBL] [Abstract][Full Text] [Related]